Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Operating expenses:
Research and development	$ 29,479	$ 12,388	$ 54,949	$ 20,601
General and administrative	6,376	4,904	12,324	9,491
Total operating expenses	35,855	17,292	67,273	30,092
Loss from operations	(35,855)	(17,292)	(67,273)	(30,092)
Other income:
Interest income	272	120	379	245
Other income	656	623	1,333	1,227
Change in fair value of CVR liability				343
Total other income	928	743	1,712	1,815
Net loss and comprehensive loss	$ (34,927)	$ (16,549)	$ (65,561)	$ (28,277)
Net loss per share attributable to common stockholders, basic	$ (0.71)	$ (0.43)	$ (1.39)	$ (0.77)
Net loss per share attributable to common stockholders, diluted	$ (0.71)	$ (0.43)	$ (1.39)	$ (0.77)
Weighted average common shares outstanding, basic	49,388,936	38,441,729	47,259,261	36,670,353
Weighted average common shares outstanding, diluted	49,388,936	38,441,729	47,259,261	36,670,353